Merlin, Inc. IPO Filing Research

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows S-1 and marks the registration effective.

2026-05-13 · 9999999995-26-001624

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

First tracked pre-IPO filing for this issuer.

2026-05-13 · 0001213900-26-055861

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows S-1 in the pre-IPO sequence.

Merlin, Inc. filed an S-1 registration statement for a secondary offering of 13,336,000 shares of common stock, including 8,000,000 PIPE Shares and 5,336,000 Warrant Shares. This replaces a prior 424B3 filing that included a larger primary offering of common stock, Series A Preferred Stock, and warrants. The current offering focuses on resale by a single selling stockholder, while the previous filing involved multiple securities and registration rights agreements.

2026-05-06 · 0001213900-26-052553

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

First tracked pre-IPO filing for this issuer.

224,514,214 shares

common stock, series a preferred stock · Exchange Nasdaq · Ticker MRLN · 760,232 Series A Preferred Investor Warrants with $12.00 exercise price · Use of proceeds Proceeds from warrant exercises, if any, will be used for general corporate purposes · Flags cayman_holding_company, warrants

Merlin, Inc. is registering a primary offering of up to 66,813,783 shares of common stock and a secondary offering of up to 157,700,431 shares of common stock, along with 736,744 shares of Series A Preferred Stock and 760,232 Series A Warrants. The prospectus outlines the resale of securities by selling securityholders, including shares from conversions of preferred stock, warrant exercises, and advisory agreements. The company will not receive proceeds from the resale but may receive proceeds if Series A Warrants are exercised. The filing emphasizes potential market volatility due to the large volume of shares being offered.

2026-04-21 · 0001213900-26-045780

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

First tracked pre-IPO filing for this issuer.

Merlin, Inc.'s S-1 registration statement became effective on April 17, 2026, following its submission to the SEC. The filing includes detailed XBRL data related to corporate structure, financial metrics, and securities offerings, but lacks explicit narrative details about business operations or strategic updates.

2026-04-17 · 9999999995-26-001246

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows S-1 in the pre-IPO sequence.

Merlin, Inc. is conducting an IPO involving the primary offering of 66,813,783 shares of common stock and a secondary offering of 157,700,431 shares of common stock, 736,744 shares of Series A preferred stock, and 760,232 Series A preferred investor warrants. The filing includes details about share conversions from Series A Preferred Stock, warrant exercises, and resale by selling securityholders. The company is a newly public entity following a business combination, with underwriters including Cohen & Company Securities, LLC (CCS) and Outside The Box Capital Inc. (OTB).

2026-04-15 · 0001213900-26-044057

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

First tracked pre-IPO filing for this issuer.

Merlin, Inc. is registering shares of common stock, including those convertible from Series A Preferred Stock and exercisable from Series A Warrants, for primary and secondary offerings. The filing includes shares held by selling securityholders, such as Bleichroeder Sponsor 1 LLC, and outlines resale provisions under a registration rights agreement. The company is an emerging growth company with reduced disclosure requirements.

2026-04-03 · 0001213900-26-039887

CERT inactive

CERT

Pre-IPO filing captured from the SEC submission timeline.

Follows 425 in the pre-IPO sequence.

Merlin, Inc. filed a CERT form on 2026-03-16, following a previous 8-A12B filing. The current filing likely relates to securities registration, though details are obscured by corrupted text. The prior 8-A12B outlined the registration of common stock for Nasdaq listing, effective March 17, 2026, with a name change from Inflection Point Acquisition Corp. IV to Merlin, Inc.

2026-03-16 · 0001354457-26-000258

8-A12B effective

Exchange Act registration

Registration filed to list the securities under the Exchange Act ahead of trading.

Follows EFFECT and registers the class of securities for exchange listing.

Merlin, Inc. is registering its common stock for listing on Nasdaq via Form 8-A12B, following its previous 425 filing related to a business combination. The current filing confirms the stock registration without additional securities, while the prior filing detailed a $105M contract for C-130J autonomy development. The company transitioned from 'Inflection Point Acquisition Corp. IV' to 'Merlin, Inc.' and emphasizes its autonomous flight technology for military applications.

2026-03-16 · 0001213900-26-028219

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows 425 in the pre-IPO sequence.

Merlin Labs, Inc. announced the completion of the Preliminary Design Review (PDR) for its C-130J autonomy program with U.S. Special Operations Command (USSOCOM), marking progress toward certification-grade autonomy. The milestone supports a $105M IDIQ contract for reduced aircrew capabilities on C-130J aircraft. The filing also references ongoing business combination discussions with Inflection Point Acquisition Corp. IV, including forward-looking statements about future milestones and market expansion.

2026-03-05 · 0001213900-26-023899

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows 425 in the pre-IPO sequence.

Merlin, Inc. announced an Investor & Analyst Webinar on March 3, 2026, as part of its ongoing business combination with Inflection Point Acquisition Corp. IV. The webinar will include a presentation and Q&A session with Merlin's management. The filing also references the previously disclosed business combination agreement, which involves Merger Sub merging into Merlin, with Merlin surviving as a subsidiary of Inflection Point. Forward-looking statements caution about risks related to the transaction's completion and future performance.

2026-02-20 · 0001213900-26-018610

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows DRS and marks the registration effective.

Merlin, Inc. (formerly Inflection Point Acquisition Corp. IV) received effectiveness for its S-4 registration statement, finalizing its business combination and domestication from the Cayman Islands to Delaware. The filing includes updated exhibits related to the merger with Merlin Labs, Inc., including the Business Combination Agreement, Plan of Domestication, and corporate governance documents. The company will rename itself to Merlin, Inc. following the transaction.

2026-02-12 · 9999999995-26-000548

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 425 and confirms the priced prospectus.

164,748,772 shares · Gross proceeds $87,300,000

Inflection Point Class A Share · Exchange NMS · Ticker MERL · Units consisting of one share of common stock and one right to receive one-tenth of one share of common stock · Series A Preferred Investor Warrants to purchase up to 24,248,102 shares of common stock · Selling stockholders only · Use of proceeds Use of proceeds not specified · Flags cayman_holding_company, units, warrants

Merlin, Inc. (formerly Inflection Point Acquisition Corp. IV) is undergoing a business combination with Merlin Labs, Inc., resulting in a name change and restructuring. The transaction involves a domestication from the Cayman Islands to Delaware, a merger with Merlin Labs, and the issuance of new securities including common stock, preferred stock, warrants, and rights. The filing outlines the conversion of existing shares, the terms of the merger, and the securities offered to shareholders.

2026-02-12 · 0001213900-26-015629

S-4/A amended

S-4/A

Pre-IPO filing captured from the SEC submission timeline.

Updates the prior 425 filing.

164,748,772 shares

Class A · Exchange NASDAQ · Ticker MERLN · Units consisting of one share of common stock and one right · Warrants exercisable for preferred stock, which will convert to common stock upon merger · Use of proceeds To facilitate the business combination and related transactions · Flags cayman_holding_company, foreign_private_issuer, units, warrants · Underwriters self-underwritten

Merlin, Inc. (formerly Inflection Point Acquisition Corp. IV) is undergoing a business combination involving a merger with Merlin Labs, Inc., resulting in a domestication from the Cayman Islands to Delaware and a name change to 'Merlin, Inc.' The transaction includes share conversions, warrant exchanges, and a $800 million purchase price for Merlin equity holders. The filing outlines the restructuring of securities, including Class A shares, rights, and units, and details the conversion of Pre-Funded Convertible Notes and Warrants. The merger is subject to shareholder approval and regulatory conditions.

2026-02-12 · 0001213900-26-015125

S-4/A amended

S-4/A

Pre-IPO filing captured from the SEC submission timeline.

Updates the prior 425 filing.

Use of proceeds Proceeds will be used for the business combination and related transactions. · Flags cayman_holding_company, foreign_private_issuer · Underwriters self-underwritten

Merlin, Inc. (formerly Inflection Point Acquisition Corp. IV) is undergoing a business combination involving a domestication from the Cayman Islands to Delaware, renaming to 'Merlin, Inc.', and merging with Merlin Labs, Inc. The filing updates exhibits and outlines the restructuring, including shareholder approvals and regulatory compliance.

2026-02-11 · 0001213900-26-014543

S-4/A amended

S-4/A

Pre-IPO filing captured from the SEC submission timeline.

Updates the prior DRS filing.

164,748,772 shares

Class A ordinary shares, Founder Shares, Series A preferred shares, units · Exchange NASDAQ · Ticker MERL · Each unit consists of one share of common stock and one right to receive one-tenth of a share of common stock · Warrants to purchase up to 24,248,102 shares of common stock · Use of proceeds Merger with Merlin Labs, Inc. resulting in a combined company · Flags cayman_holding_company, foreign_private_issuer, dual_class, units, warrants

Merlin, Inc. (formerly Inflection Point Acquisition Corp. IV) is undergoing a business combination with Merlin Labs, Inc., involving a jurisdictional change from the Cayman Islands to Delaware, a merger structure, and share conversions. The filing outlines the restructuring, including the renaming to 'Merlin, Inc.', conversion of securities, and terms for Merlin equity holders. The transaction requires shareholder approval and regulatory compliance.

2026-02-10 · 0001213900-26-013897

S-4 filed

S-4

Pre-IPO filing captured from the SEC submission timeline.

Follows 425 in the pre-IPO sequence.

653,821 shares

Class A Ordinary Shares · Unit consisting of one share of common stock and one right · Warrants exercisable for preferred stock, convertible into common stock upon exercise · Use of proceeds Proceeds will be used for merger-related expenses and working capital · Flags cayman_holding_company, foreign_private_issuer, dual_class, units, warrants

Merlin, Inc. (formerly Inflection Point Acquisition Corp. IV) is undergoing a business combination involving a domestication from the Cayman Islands to Delaware and a merger with Merlin Labs, Inc. The transaction includes share conversions, securities exchanges, and a name change to Merlin, Inc. The filing outlines the structure of the merger, shareholder approvals, and the conversion of existing securities into new equity upon completion.

2026-01-14 · 0001213900-26-004193

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows 425 in the pre-IPO sequence.

Merlin Labs, Inc. is pursuing a $1 billion business combination with Inflection Point Acquisition Corp. IV via a SPAC, aiming to go public to accelerate autonomy technology for military and civil aviation. The deal focuses on reducing flight crews, expanding autonomy applications, and leveraging AI-driven software for aircraft. The company highlights its lead in autonomous flight, partnerships with the U.S. military, and plans for future M&A to scale capabilities.

2025-12-03 · 0001213900-25-117586

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows 424B4 in the pre-IPO sequence.

Merlin Labs, Inc. announced the expansion of its executive leadership team ahead of its planned public listing via a business combination with Inflection Point Acquisition Corp. IV. The company added Leslie Ravestein as Chief Legal Officer, David Lasater as Chief People Officer, and Pablo Gonzalez as Senior Vice President of Engineering to strengthen corporate governance, talent strategy, and technical development. These appointments follow Merlin's recent $200M PIPE financing and aim to prepare the company for public market readiness.

2025-11-19 · 0001213900-25-112382

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows EFFECT in the pre-IPO sequence.

Merlin, Inc. has upsized its PIPE financing to $200M, increasing from $125M, ahead of its planned IPO via SPAC. The additional $75M comes from Inflection Point Asset Management and new institutional investors, enhancing balance sheet strength and enabling expanded defense programs, acquisitions, and hiring. The company aims to scale autonomy software across military and commercial aircraft, with a focus on C-130, KC-135, and future UAS platforms.

2025-11-18 · 0001213900-25-112132

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows CERT in the pre-IPO sequence.

Merlin, Inc. is advancing its business combination with Inflection Point Acquisition Corp. IV, involving a $100M PIPE investment increase and additional private placements. The filing details amendments to subscription agreements, new investor commitments, and registration rights, alongside ongoing preparations for shareholder approvals and regulatory filings.

2025-11-17 · 0001213900-25-111323

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows 8-A12B in the pre-IPO sequence.

Merlin, Inc. announced the appointment of Ryan Carrithers as Chief Financial Officer (CFO) as it prepares for its public listing via a business combination with Inflection Point Acquisition Corp. IV. The filing highlights Carrithers' extensive experience in aerospace and capital markets, positioning Merlin for public market readiness. The company also notes a $800 million pre-money valuation and $125 million in PIPE capital commitments, underscoring its growth trajectory and defense sector partnerships.

2025-11-04 · 0001213900-25-105669

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows S-1/A in the pre-IPO sequence.

Merlin, Inc. announced achieving Stage of Involvement (SOI) 2 with the Civil Aviation Authority of New Zealand (CAA NZ), advancing its certification process for autonomous flight technology. This follows prior SOI 1 milestones and aligns with its planned business combination with Inflection Point Acquisition Corp. IV. The update highlights progress in regulatory engagement and certification milestones as part of its pre-IPO journey.

2025-10-28 · 0001213900-25-102830

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows S-1/A in the pre-IPO sequence.

Merlin, Inc. announced a Cooperative Research and Development Agreement (CRADA) with the U.S. Air Force to enhance autonomous contingency management capabilities for uncrewed and collaborative air systems. The collaboration aims to improve mission resilience and adaptability in contested environments, leveraging Merlin's autonomy expertise and its upcoming business combination with Inflection Point Acquisition Corp. IV. The press release highlights the strategic alignment of Merlin's technology with U.S. Air Force operational priorities, emphasizing open, modular solutions for future military platforms.

2025-10-22 · 0001213900-25-101263

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

Begins the tracked draft filing sequence after 424B4.

Merlin, Inc. (formerly Bleichroeder Acquisition Corp. I) is undergoing a business combination involving a merger with Merlin Labs, Inc., resulting in a rebranding to 'Merlin Labs, Inc.' The transaction includes a domestication from the Cayman Islands to Delaware, conversion of securities, and issuance of new shares. The filing outlines the structure of the merger, shareholder approvals, and the terms of the securities to be issued.

2025-10-03 · 0001213900-25-095809

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows S-1/A in the pre-IPO sequence.

Bleichroeder Acquisition Corp. I (now Inflection Point) announced a strategic partnership between Merlin Labs and GE Aerospace to develop AI-enabled autonomy platforms for military and civil aviation. The filing updates the Business Combination timeline, mentions potential private placements to fund the partnership, and outlines the upcoming shareholder vote on the merger. The transaction remains subject to regulatory approvals and shareholder consent.

2025-09-23 · 0001213900-25-090360

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows S-1 in the pre-IPO sequence.

Bleichroeder Acquisition Corp. I (Inflection Point) has entered into a Business Combination Agreement to merge with Merlin Labs, Inc., resulting in Inflection Point renaming to Merlin Labs, Inc. The transaction involves share conversions, consideration in New Merlin Labs Common Stock, and a domestication from the Cayman Islands to Delaware. The merger is expected to close in Q1 2026 pending shareholder approval and other conditions.

2025-08-14 · 0001213900-25-076135

424B4 priced

Final prospectus

Final prospectus filed after pricing with final deal terms.

Follows 8-A12B and confirms the priced prospectus.

Price $10.00 · 25,000,000 shares · Gross proceeds $250,000,000

Each unit consists of one Class A ordinary share and one right to receive one tenth (1/10) of a Class A ordinary share upon the consummation of an initial business combination · Over-allotment 3,750,000 · Each unit consists of one Class A ordinary share and one right to receive one tenth (1/10) of a Class A ordinary share · Use of proceeds To repay loans from the sponsor and finance transaction costs related to the initial business combination · Flags cayman_holding_company, units

Bleichroeder Acquisition Corp. I, a blank check company, is conducting an IPO of 25,000,000 units at $10.00 per unit, totaling $250,000,000. The offering includes Class A ordinary shares and Share Rights, with underwriters having a 45-day option to purchase additional units. The company will provide redemption rights for public shareholders upon completing an initial business combination, subject to limitations. The sponsor, Bleichroeder Sponsor 1 LLC, has committed to a private placement of 425,000 units, with Inflection Point Fund I LP expressing interest in purchasing all units. Founder shares will convert to Class A shares upon a business combination, with anti-dilution protections. The company has 24 months to complete a business combination or face liquidation.

2024-11-01 · 0001213900-24-093200

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows S-1/A and marks the registration effective.

The filing marks the effectiveness of Bleichroeder Acquisition Corp. I's S-1 registration statement for an initial public offering (IPO) of 25,000,000 units at $10.00 per unit. The company, a blank check entity, aims to pursue a business combination but has not yet identified a target. The offering includes redemption rights for public shareholders and private placement units purchased by the sponsor and Inflection Point Fund I LP. The filing emphasizes risks related to the sponsor's potential losses, conflicts of interest, and limitations on shareholder redemptions.

2024-10-31 · 9999999995-24-003326

CERT inactive

CERT

Pre-IPO filing captured from the SEC submission timeline.

First tracked pre-IPO filing for this issuer.

The current filing for Merlin, Inc. is a CERT form, indicating registration of securities under Section 12(g) of the Securities Exchange Act. However, the filing text appears corrupted or non-readable, limiting insights into specific details. The previous 8-A12B filing detailed securities registration for Bleichroeder Acquisition Corp. I, including units, Class A shares, and rights. No clear updates or changes are visible in the current filing due to text corruption.

2024-10-31 · 0001354457-24-000841

8-A12B effective

Exchange Act registration

Registration filed to list the securities under the Exchange Act ahead of trading.

Follows EFFECT and registers the class of securities for exchange listing.

Bleichroeder Acquisition Corp. I filed Form 8-A12B to register securities under Section 12(b) of the Securities Exchange Act of 1934. The filing includes units, Class A ordinary shares, and rights to receive Class A shares, referencing a prospectus from its prior S-1 registration statement (File No. 333-280777). The registration is effective as of October 31, 2024, and incorporates by reference the prospectus details from the S-1 filing.

2024-10-31 · 0001213900-24-092616

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Price $10.00 · 25,000,000 shares · Gross proceeds $250,000,000

Class A · Over-allotment 3,750,000 · Each unit consists of one Class A ordinary share and one Share Right to receive 1/10 of a Class A ordinary share · Use of proceeds Proceeds from this offering will be used for the company's initial business combination and related expenses · Flags cayman_holding_company, units

Bleichroeder Acquisition Corp. I, a Cayman Islands exempted company, is conducting an IPO to raise $250 million through the sale of 25 million units at $10 each. Each unit includes one Class A ordinary share and a right to receive 1/10 of a Class A share upon a business combination. The company has not yet identified a target and may pursue any industry. The sponsor, Bleichroeder Sponsor 1 LLC, has committed to purchasing private placement units, with Inflection Point Fund I LP expressing interest in indirectly acquiring all 425,000 units. The offering includes redemption rights for public shareholders and potential conversion of founder shares.

2024-10-23 · 0001213900-24-089753

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Price $10.00 · 25,000,000 shares · Gross proceeds $250,000,000

One Class A ordinary share and one right to receive one tenth (1/10) of a Class A ordinary share upon the consummation of an initial business combination · Over-allotment 3,750,000 · One Class A ordinary share and one right to receive one tenth (1/10) of a Class A ordinary share upon the consummation of an initial business combination · Use of proceeds To facilitate the initial business combination · Flags cayman_holding_company, units

Bleichroeder Acquisition Corp. I, a Cayman Islands blank check company, is conducting an IPO of 25,000,000 units at $10.00 per unit. Each unit includes one Class A ordinary share and a right to receive 1/10 of a Class A share upon a business combination. The filing includes updated details on private placement units, sponsor commitments, and redemption rights for public shareholders. The company has until 24 months from the offering's close to complete its initial business combination.

2024-10-07 · 0001213900-24-085900

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1 filing.

Price $10.00 · 25,000,000 shares · Gross proceeds $250,000,000

Class A ordinary share · Ticker BACI · Over-allotment 3,750,000 · One Class A ordinary share and one-quarter of one redeemable warrant · Each warrant entitles the holder to purchase one Class A ordinary share at $11.50 per share · Use of proceeds For the initial business combination and working capital · Flags cayman_holding_company, units, warrants

Bleichroeder Acquisition Corp. I, a Cayman Islands blank check company, is conducting an IPO to raise $250 million through the sale of 25,000,000 units. Each unit includes one Class A ordinary share and a quarter of a redeemable warrant. The company has not yet identified a business combination target and aims to complete a merger, acquisition, or similar transaction within 24 months (or 27 months under certain conditions). The filing includes updated terms for sponsor commitments, redemption rights, and conversion of founder shares.

2024-08-21 · 0001213900-24-071383

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

First tracked pre-IPO filing for this issuer.

Price $10.00 · 25,000,000 shares · Gross proceeds $250,000,000

Class A ordinary share and one-quarter of one redeemable warrant · Exchange NASDAQ · Ticker BLCR · Over-allotment 3,750,000 · One Class A ordinary share and one-quarter of one redeemable warrant · Each warrant entitles holder to purchase one Class A ordinary share at $11.50 per share, exercisable 30 days after initial business combination · Use of proceeds For working capital and potential initial business combination · Flags cayman_holding_company, units, warrants

Bleichroeder Acquisition Corp. I, a Cayman Islands exempted company, is conducting an IPO to raise $250 million through the sale of 25,000,000 units at $10.00 per unit. Each unit includes one Class A ordinary share and one-quarter of a redeemable warrant. The company is a blank check firm seeking a merger, acquisition, or business combination but has not yet identified a target. Proceeds will be held in a trust account, with redemption rights for public shareholders and a sponsor commitment to purchase warrants. The offering includes underwriter over-allotment options and potential extensions for completing a business combination.

2024-07-12 · 0001213900-24-061026

Merlin, Inc.

Filing Timeline

17 comparable deals

Recent News